Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Neuroscience Neurology process Neurodegenerative disease Parkinson's disease Parkin / PARK

Anti-PARK7/DJ1 antibody [EPR19466-105] (ab201147)

Price and availability

278 083 ₸

Availability

Order now and get it on Tuesday March 02, 2021

Anti-PARK7/DJ1 antibody [EPR19466-105] (ab201147)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
  • Rabbit monoclonal [EPR19466-105] to PARK7/DJ1
  • Suitable for: WB, Flow Cyt, ICC/IF, IP
  • Reacts with: Human

You may also be interested in

Human PARK7/DJ1 peptide (ab18659)
Product image
Anti-PARK7/DJ1 antibody [MJF-R16 (66-5)] - BSA and Azide free (ab218374)
Product image
Anti-AIMP2/p38 antibody (ab180897)
Product image
Anti-Parkin antibody [PRK8] - BSA and Azide free (ab264105)

Overview

  • Product name

    Anti-PARK7/DJ1 antibody [EPR19466-105]
    See all PARK7/DJ1 primary antibodies
  • Description

    Rabbit monoclonal [EPR19466-105] to PARK7/DJ1
  • Host species

    Rabbit
  • Tested Applications & Species

    Application Species
    Flow Cyt
    Human
    ICC/IF
    Human
    IP
    Human
    WB
    Human
    See all applications and species data
  • Immunogen

    Recombinant full length protein. This information is proprietary to Abcam and/or its suppliers.

  • Positive control

    • WB; HeLa, HEK-293T and LNCaP whole cell lysate. Human brain, fetal heart, fetal kidney and fetal spleen lysate. ICC/IF: HeLa and LNCaP cells. Flow Cytometry: HeLa cells. IP: HEK-293T whole cell lysate.
  • General notes

    This product is a recombinant monoclonal antibody, which offers several advantages including:

    • - High batch-to-batch consistency and reproducibility
    • - Improved sensitivity and specificity
    • - Long-term security of supply
    • - Animal-free production
    For more information see here.

    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

    Reproducibility is key to advancing scientific discovery and accelerating scientists’ next breakthrough.

    Abcam is leading the way with our range of recombinant antibodies, knockout-validated antibodies and knockout cell lines, all of which support improved reproducibility.

    We are also planning to innovate the way in which we present recommended applications and species on our product datasheets, so that only applications & species that have been tested in our own labs, our suppliers or by selected trusted collaborators are covered by our Abpromise™ guarantee.

    In preparation for this, we have started to update the applications & species that this product is Abpromise guaranteed for.

    We are also updating the applications & species that this product has been “predicted to work with,” however this information is not covered by our Abpromise guarantee.

    Applications & species from publications and Abreviews that have not been tested in our own labs or in those of our suppliers are not covered by the Abpromise guarantee.

    Please check that this product meets your needs before purchasing. If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, as well as customer reviews and Q&As.

Properties

  • Form

    Liquid
  • Storage instructions

    Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle.
  • Storage buffer

    pH: 7.2
    Preservative: 0.01% Sodium azide
    Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
  • Concentration information loading...
  • Purity

    Protein A purified
  • Clonality

    Monoclonal
  • Clone number

    EPR19466-105
  • Isotype

    IgG
  • Research areas

    • Neuroscience
    • Neurology process
    • Neurodegenerative disease
    • Parkinson's disease
    • Parkin / PARK
    • Signal Transduction
    • Signaling Pathway
    • G Protein Signaling
    • Small G Proteins
    • Regulators
    • Epigenetics and Nuclear Signaling
    • Chromatin Binding Proteins
    • DNA / RNA binding
    • Cancer
    • Signal transduction
    • G protein signaling
    • Small G proteins
    • Other
    • Metabolism
    • Pathways and Processes
    • Redox metabolism
    • Oxidative stress

Images

  • Western blot - Anti-PARK7/DJ1 antibody [EPR19466-105] (ab201147)
    Western blot - Anti-PARK7/DJ1 antibody [EPR19466-105] (ab201147)
    All lanes : Anti-PARK7/DJ1 antibody [EPR19466-105] (ab201147) at 1/5000 dilution

    Lane 1 : HeLa (human cervix adenocarcinoma) whole cell lysate
    Lane 2 : HEK-293T (human embryonic kidney) whole cell lysate
    Lane 3 : LNCaP (human prostate carcinoma) whole cell lysate

    Lysates/proteins at 20 µg per lane.

    Secondary
    All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution

    Predicted band size: 20 kDa
    Observed band size: 23 kDa
    why is the actual band size different from the predicted?


    Exposure time: 5 seconds


    Blocking and dilution buffer: 5% NFDM/TBST.

  • Immunocytochemistry/ Immunofluorescence - Anti-PARK7/DJ1 antibody [EPR19466-105] (ab201147)
    Immunocytochemistry/ Immunofluorescence - Anti-PARK7/DJ1 antibody [EPR19466-105] (ab201147)

    Immunofluorescent analysis of 100% methanol fixed HeLa (human epithelial cell line from cervix adenocarcinoma) cells labeling PARK7/DJ1 with ab201147 at 1/100 dilution, followed by AlexaFluor®488 Goat anti-Rabbit (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing cytoplasmic and weak nuclear staining on HeLa cells.

    The nuclear counter stain is DAPI (blue). Tubulin is detected with Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594)(ab195889) at 1/200 dilution (red). 

    Secondary antibody only control: Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution.

  • Flow Cytometry - Anti-PARK7/DJ1 antibody [EPR19466-105] (ab201147)
    Flow Cytometry - Anti-PARK7/DJ1 antibody [EPR19466-105] (ab201147)

    Flow cytometric analysis of 4% paraformaldehyde fixed HeLa (human cervix adenocarcinoma) cell line labeling PARK7/DJ1 with ab201147 at 1/120 (red) compared with a Rabbit monoclonal IgG (ab172730) (black) and an unlabeled control (cells without incubation with primary antibody and secondary antibody) (blue). Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077), at 1/2000 dilution was used as the secondary antibody.

  • Immunoprecipitation - Anti-PARK7/DJ1 antibody [EPR19466-105] (ab201147)
    Immunoprecipitation - Anti-PARK7/DJ1 antibody [EPR19466-105] (ab201147)

    PARK7/DJ1 was immunoprecipitated from 0.35 mg HEK-293T (human embryonic kidney) whole cell lysate with ab201147 at 1/60 dilution. Western blot was performed from the immunoprecipitate using ab201147 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.
    Lane 1: HEK-293T (human embryonic kidney) whole cell lysate  10 μg (Input).
    Lane 2: HEK-293T whole cell lysate.
    Lane 3: Rabbit monoclonal IgG (ab172730) instead of ab201147 in HEK-293T whole cell lysate.
    Blocking and dilution buffer and concentration: 5% NFDM/TBST.
    Exposure time: 3 seconds.

  • Western blot - Anti-PARK7/DJ1 antibody [EPR19466-105] (ab201147)
    Western blot - Anti-PARK7/DJ1 antibody [EPR19466-105] (ab201147)
    All lanes : Anti-PARK7/DJ1 antibody [EPR19466-105] (ab201147) at 1/5000 dilution

    Lane 1 : Human brain lysate
    Lane 2 : Human fetal heart lysate
    Lane 3 : Human fetal kidney lysate
    Lane 4 : Human fetal spleen lysate

    Lysates/proteins at 10 µg per lane.

    Secondary
    All lanes : VeriBlot for IP Detection Reagent (HRP) (ab131366) at 1/4000 dilution

    Predicted band size: 20 kDa
    Observed band size: 23 kDa why is the actual band size different from the predicted?


    Exposure time: 5 seconds


    Blocking and dilution buffer: 5% NFDM/TBST.

  • Immunocytochemistry/ Immunofluorescence - Anti-PARK7/DJ1 antibody [EPR19466-105] (ab201147)
    Immunocytochemistry/ Immunofluorescence - Anti-PARK7/DJ1 antibody [EPR19466-105] (ab201147)

    Immunofluorescent analysis of 100% methanol fixed LNCaP (Human prostate cancer cell line) cells labeling PARK7/DJ1 with ab201147 at 1/100 dilution, followed by  AlexaFluor®488 Goat Anti-Rabbit (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing cytoplasmic and weak nuclear staining on LNCaP cells.

    The nuclear counter stain is DAPI (blue). Tubulin is detected with Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594)(ab195889) at 1/200 dilution (red). 

    Secondary antibody only control: Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution.

  • Anti-PARK7/DJ1 antibody [EPR19466-105] (ab201147)
    Anti-PARK7/DJ1 antibody [EPR19466-105] (ab201147)

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Alternative products to Anti-PARK7/DJ1 antibody [EPR19466-105] (ab201147)

  •  
  • Product image

    Alexa Fluor® 594 Anti-PARK7/DJ1 antibody [EP2815Y] (ab215102)

    Applications: ICC/IF

  •  
  • Product image

    Anti-PARK7/DJ1 antibody [EPR19466-1-8] (ab222667)

    Applications: sELISA

  •  
  • Product image

    Anti-PARK7/DJ1 antibody [MJF-R16 (66-5)] - Oxidized (ab169520)

    Applications: WB

  •  
  • Product image

    Anti-PARK7/DJ1 antibody (ab226827)

    Applications: IHC-P, WB

  •  
  • Product image

    Anti-PARK7/DJ1 antibody [EPR19466-105] - BSA and Azide free (ab224529)

    Applications: Flow Cyt, ICC/IF, IP, WB

  •  
  • Product image

    Anti-PARK7/DJ1 antibody [EP2815Y] (ab76008)

    Applications: Flow Cyt, ICC/IF, IHC-P, IP, WB

  •  
  • Product image

    Alexa Fluor® 488 Anti-PARK7/DJ1 antibody [EP2815Y] (ab203989)

    Applications: Flow Cyt, ICC/IF

  •  
  • Product image

    Anti-PARK7/DJ1 antibody [EPR19466-105] (ab222668)

    Applications: sELISA

  •  
  • Product image

    Anti-PARK7/DJ1 antibody (ab265596)

    Applications: IHC-P, IP, WB

Clear all

Recently viewed products

  •  
  • Product image

    Anti-Caldesmon/CDM antibody [E89] (ab32330)

  •  
  • Product image

    Anti-FAK antibody [EP695Y] (ab40794)

  •  
  • Product image

    Anti-PAX5 antibody [SP34] - ChIP Grade (ab227635)

  •  
  • Product image

    Anti-F4/80 antibody [BM8] (ab16911)

  •  
  • Product image

    Anti-PPP1CB antibody [EP1804Y] (ab53315)

  •  
  • Product image

    Anti-FNDC5 antibody [EPR12209] (ab174833)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.